HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Operating Expenses
HLS Therapeutics Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Operating Expenses
-$71.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-31%
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Operating Expenses
-CA$965.4k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
32%
|
CAGR 10-Years
15%
|
See Also
What is HLS Therapeutics Inc's Operating Expenses?
Operating Expenses
-71.1m
USD
Based on the financial report for Mar 31, 2024, HLS Therapeutics Inc's Operating Expenses amounts to -71.1m USD.
What is HLS Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-31%
Over the last year, the Operating Expenses growth was 5%. The average annual Operating Expenses growth rates for HLS Therapeutics Inc have been -3% over the past three years , -6% over the past five years , and -31% over the past ten years .